Brian Lind

Brian Lind serves as a primary procurement lead at the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS), where he oversees acquisitions critical to accelerating biomedical innovation. His responsibilities include managing the procurement of advanced laboratory technologies, analytical instrumentation, and specialized research services that support translational research pipelines. He plays a pivotal role in aligning contracting strategies with NCATS’s mission to bridge the gap between discovery and clinical application, ensuring timely access to cutting-edge tools such as tissue chip systems, high-throughput screening platforms, and precision metabolite synthesis technologies. His acquisitions primarily support R&D infrastructure, laboratory automation, and analytical service providers essential to preclinical validation. While no specific contractor relationships are currently identifiable, Brian engages with a diverse ecosystem of vendors including precision instrument manufacturers, independent testing laboratories, and biopharmaceutical process developers. He fosters collaborative partnerships with firms capable of delivering validated, scalable solutions for complex biological assays and automated analytical workflows. His procurement approach emphasizes technical capability, regulatory compliance, and rapid deployment to meet the dynamic needs of translational science teams. Brian demonstrates a strong commitment to small business participation, with nearly 28% of his acquisitions structured as total small business set-asides under FAR 19.5. His contracting patterns reflect a deliberate effort to enable innovation from emerging vendors, particularly those with expertise in specialized laboratory services and instrumentation. While no other socioeconomic set-asides are predominant, his portfolio consistently prioritizes small business eligibility, reinforcing NCATS’s broader goal of diversifying the supplier base in biomedical R&D. His primary procurement focus centers on NAICS codes related to analytical laboratory services, precision equipment maintenance, and biological product manufacturing. He frequently procures high-performance mass spectrometers, automated liquid handling systems, and contract research services for metabolomic profiling and biological candidate screening, demonstrating deep technical fluency in life sciences instrumentation and translational research infrastructure.